South Korea
· Delayed Price · Currency is KRW SG HealthCare Statistics
Total Valuation
SG HealthCare has a market cap or net worth of KRW 35.87 billion. The enterprise value is 35.28 billion.
| Market Cap | 35.87B |
| Enterprise Value | 35.28B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SG HealthCare has 10.76 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 10.76M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 31.58% |
| Owned by Institutions (%) | 4.79% |
| Float | 7.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.23 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 32.29 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.94 |
| EV / Sales | 2.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.02 |
Financial Position
The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.31.
| Current Ratio | 3.62 |
| Quick Ratio | 2.33 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.39 |
| Interest Coverage | -1.39 |
Financial Efficiency
Return on equity (ROE) is -19.60% and return on invested capital (ROIC) is -1.62%.
| Return on Equity (ROE) | -19.60% |
| Return on Assets (ROA) | -1.43% |
| Return on Invested Capital (ROIC) | -1.62% |
| Return on Capital Employed (ROCE) | -2.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.01 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 3,207.60 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 52.59 |
| Average Volume (20 Days) | 2,407,923 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SG HealthCare had revenue of KRW 16.10 billion and -3.55 billion in losses. Loss per share was -386.39.
| Revenue | 16.10B |
| Gross Profit | 5.14B |
| Operating Income | -673.10M |
| Pretax Income | -3.66B |
| Net Income | -3.55B |
| EBITDA | -303.90M |
| EBIT | -673.10M |
| Loss Per Share | -386.39 |
Balance Sheet
The company has 7.70 billion in cash and 7.03 billion in debt, giving a net cash position of 671.21 million or 62.41 per share.
| Cash & Cash Equivalents | 7.70B |
| Total Debt | 7.03B |
| Net Cash | 671.21M |
| Net Cash Per Share | 62.41 |
| Equity (Book Value) | 22.70B |
| Book Value Per Share | 2,103.16 |
| Working Capital | 15.90B |
Cash Flow
In the last 12 months, operating cash flow was 1.11 billion and capital expenditures -4.05 billion, giving a free cash flow of -2.94 billion.
| Operating Cash Flow | 1.11B |
| Capital Expenditures | -4.05B |
| Free Cash Flow | -2.94B |
| FCF Per Share | -272.95 |
Margins
Gross margin is 31.89%, with operating and profit margins of -4.18% and -22.03%.
| Gross Margin | 31.89% |
| Operating Margin | -4.18% |
| Pretax Margin | -22.70% |
| Profit Margin | -22.03% |
| EBITDA Margin | -1.89% |
| EBIT Margin | -4.18% |
| FCF Margin | n/a |
Dividends & Yields
SG HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -9.89% |
| FCF Yield | -8.18% |
Stock Splits
The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.3285691.
| Last Split Date | Dec 4, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.3285691 |
Scores
SG HealthCare has an Altman Z-Score of 1.7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.7 |
| Piotroski F-Score | n/a |